KARPAS 299 Lymphoma Cell Line
Human Non-Hodgkin's Ki-positive Large Cell Lymphoma cell lines
Technology No. KAR-6345-19
KARPAS 299 Human Non-Hodgkin’s Ki-positive Large Cell Lymphoma cell line useful in oncology research, developed at the University of Cambridge.
Cambridge Enterprise Limited is the exclusive licensor for the Karpas cell line portfolio. We have partnered with ECACC (The European Collection of Cell Cultures; a Public Health England Culture Collection) to manage distribution of the majority of these cells on our behalf. Enquires to either organisation are welcomed.
-
swap_vertical_circlemode_editAuthors (1)Abraham Karpas
-
swap_vertical_circlelibrary_booksReferences (4)
- Ficsher et al. (1988), A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene, Blood, 72, 234–240
- Wolke et al. (2006), Assigning the phenotype of a natural regulatory T-cell to the human T-cell line, KARPAS-299, International Journal of Molecular Medicine, 17, 275-278
- Drexler et al. (2004), Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations, Leukemia, 18, 1569-1571
- Fillmore et al. (2002), Gene expression profiling of cell lines derived from T-cell malignancies, FEBS Lett., 522, 183-185
-
swap_vertical_circlecloud_downloadSupporting documents (1)Product brochureKARPAS 299 Lymphoma Cell Line.pdfAdditional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Sign up to our newsletter
If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.